Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Assets (2021 - 2025)

Vivos Therapeutics' Return on Assets history spans 5 years, with the latest figure at 0.84% for Q4 2025.

  • Quarterly results put Return on Assets at 0.84% for Q4 2025, down 11.0% from a year ago — trailing twelve months through Dec 2025 was 0.84% (down 11.0% YoY), and the annual figure for FY2025 was 1.05%, down 19.0%.
  • Return on Assets for Q4 2025 was 0.84% at Vivos Therapeutics, down from 0.66% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.71% in Q3 2023 to a low of 1.39% in Q1 2024.
  • The 5-year median for Return on Assets is 0.5% (2021), against an average of 0.44%.
  • The sharpest move saw Return on Assets skyrocketed 94bps in 2023, then crashed -163bps in 2024.
  • Year by year, Return on Assets stood at 0.0% in 2021, then surged by 1112bps to 0.01% in 2022, then plummeted by -21039bps to 1.29% in 2023, then surged by 44bps to 0.73% in 2024, then decreased by -15bps to 0.84% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.84%, 0.66%, and 0.77% for Q4 2025, Q3 2025, and Q2 2025 respectively.